WHO ICTRP trial
Immune Decoding for the Malignant Progression of Pulmonary Nodules
ChiCTR2500111469 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500111469 |
|---|---|
| Public title | Immune Decoding for the Malignant Progression of Pulmonary Nodules |
| Scientific title | Immune Decoding for the Malignant Progression of Pulmonary Nodules |
| Primary sponsor | The First Hospital of Jilin University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Pulmonary nodules |
| Interventions | Observation group:None;Healthy volunteer group:None |
| Registration date | Oct 31, 2025 |
| Target size | Observation group:650;Healthy volunteer group:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: